- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/24 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 241/24
Total number of patents in this class: 348
10-year publication summary
25
|
24
|
23
|
26
|
18
|
33
|
14
|
27
|
14
|
10
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Toyama Chemical Co., Ltd. | 102 |
13 |
Theravance Biopharma R&D IP, LLC | 456 |
11 |
Amgen Inc. | 4076 |
9 |
Nihon Nohyaku Co., Ltd. | 327 |
8 |
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 165 |
7 |
The University of Queensland | 661 |
7 |
FUJIFILM Toyama Chemical Co., Ltd. | 111 |
7 |
Syngenta Crop Protection AG | 6074 |
6 |
Bristol-myers Squibb Company | 4880 |
5 |
AstraZeneca AB | 2892 |
5 |
Bayer Cropscience AG | 2040 |
5 |
Nippon Soda Co., Ltd. | 895 |
5 |
F. Hoffmann-La Roche AG | 7947 |
4 |
Syngenta Participations AG | 1904 |
4 |
The Hong Kong University of Science and Technology | 754 |
4 |
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 185 |
4 |
The University of Sydney | 600 |
4 |
Laurus Labs Limited | 100 |
4 |
Novartis AG | 10744 |
3 |
BASF SE | 20940 |
3 |
Other owners | 230 |